You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Paliperidone Palmitate

Showing 1 - 25 of 241
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Schizophrenia Trial in Rwanda (Risperidone 3 mg, Paliperidone Palmitate 50 mg eq., Paliperidone Palmitate 75 mg eq.)

Recruiting
  • Schizophrenia
  • Risperidone 3 mg
  • +8 more
  • Butare, Rwanda
  • +4 more
Jan 3, 2023

Schizophrenia (Recent-onset) Trial in Los Angeles (paliperidone palmitate, risperidone)

Completed
  • Schizophrenia (Recent-onset)
  • Los Angeles, California
    UCLA Semel Institute for Neuroscience and Human Behavior
Apr 7, 2022

Schizophrenia, Psychotic Disorders, Mood Disorders Trial in United States (LY03010 156 mg treatment group, deltoid, LY03010 156

Recruiting
  • Schizophrenia
  • +11 more
  • LY03010 156 mg treatment group, deltoid
  • +3 more
  • Little Rock, Arkansas
  • +8 more
Apr 11, 2022

Paliperidone Palmitate on Clinical Outcomes and Hospital

Completed
  • Schizophrenia
  • Oral Antipsychotics (OAPs)
  • Paliperidone Palmitate 1-Month Formulation (PP1M)
  • Porto, Portugal, Portugal
    Neurobios , Instituto De Neurociências
Jul 12, 2021

Breakthrough Symptoms With Long-Acting Injectable Medications

Not yet recruiting
  • Schizophrenia
  • Schizophrenia Relapse
  • Second Generation Long-Acting Injectable Antipsychotic Medications
  • (no location specified)
Jul 22, 2022

Schizophrenics Trial (Paliperidone Palmitate 156 MG/ML Prefilled Syringe [Invega], Paliperidone Palmitate 546 MG Intramuscular

Completed
  • Schizophrenics
  • Paliperidone Palmitate 156 MG/ML Prefilled Syringe [Invega]
  • Paliperidone Palmitate 546 MG Intramuscular Suspension, Extended Release [INVEGA TRINZA]
  • (no location specified)
Feb 12, 2021

Schizophrenia Trial in Kigali, Musanze District, Ngoma District (Risperidone 3 mg, Paliperidone Palmitate 50 mg eq.,

Completed
  • Schizophrenia
  • Risperidone 3 mg
  • +8 more
  • Kigali, Rwanda
  • +2 more
Nov 13, 2020

Schizophrenia Trial in Worldwide (PP6M injection Dose 1, PP6M injection Dose 2)

Completed
  • Schizophrenia
  • PP6M injection Dose 1
  • PP6M injection Dose 2
  • Ciudad Autónoma De Buenos Aires, Argentina
  • +29 more
Jul 14, 2022

Tolerability of Paliperidone Palmitate in Korean Schizophrenic

Completed
  • Schizophrenia
  • No intervention
  • KyungKi, Korea, Republic of
    (unnamed)
Feb 1, 2021

Schizophrenia, Psychotic Disorders, Mood Disorders Trial in United States (LY03010; paliperidone palmitate, INVEGA SUSTENNA)

Active, not recruiting
  • Schizophrenia
  • +11 more
  • LY03010; paliperidone palmitate
  • INVEGA SUSTENNA
  • Garden Grove, California
  • +8 more
Nov 19, 2021

Schizophrenia Patients Trial in Berlin (Paliperidone Palmitate)

Completed
  • Schizophrenia Patients
  • Paliperidone Palmitate
  • Berlin, New Jersey
    Hassman Research Institute
Nov 5, 2020

Schizophrenia Trial in United States (Aripiprazole Lauroxil, Paliperidone Palmitate)

Completed
Has Results
  • Schizophrenia
  • Aripiprazole Lauroxil
  • Paliperidone Palmitate
  • Little Rock, Arkansas
  • +15 more
Jul 29, 2020

Long-acting Antipsychotics on Schizophrenia Violence Risk

Unknown status
  • Schizophrenia
  • Paliperidone Palmitate
  • Wuhan, Hubei, China
    Wuhan mental health center
Feb 19, 2020

Schizophrenia Trial in Worldwide (PP6M, PP3M 350 mg eq., PP3M 525 mg eq.)

Completed
Has Results
  • Schizophrenia
  • Rogers, Arkansas
  • +137 more
Nov 11, 2021

Schizophrenia, Treatment-resistant Schizophrenia, Side Effect Trial (Aripiprazole, Paliperidone)

Not yet recruiting
  • Schizophrenia
  • +6 more
  • (no location specified)
Sep 27, 2023

Schizophrenia Trial in Catonsville (Paliperidone)

Withdrawn
  • Schizophrenia
  • Catonsville, Maryland
    Maryland Psychiatric Research Center
Mar 1, 2022

Long-acting Antipsychotics for Mental Ill-Health in Pregnancy

Not yet recruiting
  • Schizophrenia
  • +7 more
    • Makurdi, Benue State, Nigeria
    • +5 more
    Mar 9, 2023

    Schizophrenia Trial in Worldwide (Paliperidone palmitate 3 month formulation (PP3M))

    Completed
    • Schizophrenia
    • Paliperidone palmitate 3 month formulation (PP3M)
    • Rijeka, Croatia
    • +45 more
    Apr 17, 2019

    Psychotic Disorders, Schizophrenia, Schizoaffective Disorder Trial in Cleveland (CAE-L)

    Completed
    Has Results
    • Psychotic Disorders
    • +4 more
    • CAE-L
    • Cleveland, Ohio
      University Hospitals Case Medical Center
    Dec 6, 2019

    Assessment of Schizophrenia Patients' Clinical Study Experiences

    Not yet recruiting
    • Schizophrenia
      • San Francisco, California
        Power Life Sciences
      Jul 7, 2023

      Stimulant Use With Stimulant-Induced Psychotic Disorder (Diagnosis), Schizophrenia and Related Disorders, Stimulant Dependence

      Recruiting
      • Stimulant Use With Stimulant-Induced Psychotic Disorder (Diagnosis)
      • +4 more
      • Hong Kong, Hong Kong
        Queen Mary Hospital
      Aug 17, 2021

      Schizophrenia Trial (Fecal microbiota transplantation(FMT), Placebo)

      Not yet recruiting
      • Schizophrenia
      • Fecal microbiota transplantation(FMT)
      • Placebo
      • (no location specified)
      May 6, 2023

      Treatment-resistant Schizophrenia Trial in Columbus (Clozapine, Antipsychotics,Other (non-Clozapine))

      Not yet recruiting
      • Treatment-resistant Schizophrenia
      • Columbus, Ohio
        Ohio State University Harding Hospital
      Feb 22, 2023

      Schizophrenia Trial in Worldwide (Aripiprazole, Aripiprazole depot, Paliperidone)

      Completed
      • Schizophrenia
      • Innsbruck, Anichstrasse 35, Austria
      • +48 more
      Aug 31, 2020

      Schizophrenia, Antipsychotics, Long-Acting Injection Trial in Korea, Republic of (Abilify maintena)

      Completed
      • Schizophrenia
      • +4 more
      • Abilify maintena
      • Chungju, Chungcheongbuk-do, Korea, Republic of
      • +26 more
      Dec 16, 2021